Taken together, the aforementioned data demonstrate that ERK5 signaling inhibition suppresses malignant stem-like phenotypes and function, and support the notion that MEK5/ERK5 is required for sustained stemness in colon cancer cells. The gene discussed is MAP2K5; the disease is colonic neoplasm.